Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/91180
Title: Sleeping Beauty insertional mutagenesis screen identifies the pro-metastatic roles of CNPY2 and ACTN2 in hepatocellular carcinoma tumor progression
Authors: Lo, LH 
Lam, CY 
To, JC 
Chiu, CH 
Keng, VW 
Issue Date: 19-Feb-2021
Source: Biochemical and biophysical research communications, 19 Feb. 2021, v. 541, p. 70-77
Abstract: A forward genetic Sleeping Beauty (SB) insertional mutagenesis screen, followed by high-throughput transcriptome sequencing, was used to identify driver genes responsible for hepatocellular carcinoma (HCC)-associated metastasis. Using RNA-sequencing (RNA-seq) to identify transposon-endogenous transcriptome fusion genes, the phylogenetic lineage between the parental liver tumor and secondary metastasis can be determined to provide mechanistic insight to genetic changes involved in the metastatic evolution process. In the current study, two novel candidate genes were identified to be potentially involved in HCC-associated metastatic progression, canopy FGF signaling regulator 2 (Cnpy2) and actinin alpha 2 (Actn2). Transposon-Cnpy2 fusion transcripts were identified in both primary liver tumors and lung metastases. Its significant association with clinicopathological characteristics and correlated gene enrichment in metastasis-related mechanisms suggest its potential role in modulating local invasion and angiogenesis. Other known driver genes for human HCC that can also promote metastatic progression include epidermal growth factor receptor (Egfr) and RNA imprinted and accumulated in nucleus (Rian). Metabolic pathway related gene carbamoyl phosphate synthetase (Cps1) was identified to play an important role in early HCC development, while cell junction-related pathway gene Rac family small GTPase 1 (Rac1) was identified to take part in both HCC and pro-metastatic progression. Importantly, actinin alpha 2 (Actn2) was identified exclusively in the secondary metastasis site and its role in HCC-related metastatic process was elucidated using in vitro approaches. ACTN2-overexpression in human liver cancer cells displayed enhanced cellular motility and invasion abilities, indicating its possible function in later stage of metastasis, such as extravasation and lung colonization.
Keywords: Hepatocellular carcinoma
Sleeping Beauty
Forward genetic screen
CNPY2
ACTN2
Metastasis
Publisher: Elsevier
Journal: Biochemical and biophysical research communications 
ISSN: 0006-291X
EISSN: 1090-2104
DOI: 10.1016/j.bbrc.2021.01.017
Rights: ©2021 Elsevier Inc. All rights reserved.
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
BBRC-20-10325.pdfPre-Print version2.58 MBAdobe PDFView/Open
Access
View full-text via PolyU eLinks SFX Query
Show full item record
PIRA download icon_1.1View/Download Full Text

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.